We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$211M
AUM Growth
+$4.37M
Cap. Flow
-$6.46M
Cap. Flow %
-3.07%
Top 10 Hldgs %
31.01%
Holding
69
New
12
Increased
18
Reduced
24
Closed
9

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$6.79M
2
UNH icon
UnitedHealth
UNH
+$5.84M
3
TMO icon
Thermo Fisher Scientific
TMO
+$4.67M
4
HCA icon
HCA Healthcare
HCA
+$3.84M
5
ELV icon
Elevance Health
ELV
+$3.44M

Top Sells

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$6.31M
2
GILD icon
Gilead Sciences
GILD
+$5.4M
3
CVS icon
CVS Health
CVS
+$5.31M
4
HUM icon
Humana
HUM
+$5.26M
5
CI icon
Cigna
CI
+$4.81M

Sector Composition

Rank Sector Weight
1 Healthcare 87.1%
2 Financials 2.57%
3 Energy 1.89%
4 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
26
Quest Diagnostics
DGX
$26.3B
$3.56M 1.69%
50,000
+20,000
+67% +$1.34M
ELV icon
27
Elevance Health
ELV
$84.3B
$3.49M 1.66%
+25,000
New +$3.44M
MDT icon
28
Medtronic
MDT
$116B
$3.46M 1.64%
45,000
– –
LLY icon
29
Eli Lilly
LLY
$1.08T
$3.37M 1.6%
40,000
-20,000
-33% -$1.66M
WAT icon
30
Waters Corp
WAT
$40.7B
$3.37M 1.6%
+25,000
New +$3.21M
INCY icon
31
Incyte
INCY
$24.5B
$3.22M 1.53%
29,693
+2,693
+10% +$300K
AMED
32
DELISTED
Amedisys
AMED
$3.15M 1.49%
80,000
+200
+0.3% +$8K
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$13.5B
$2.92M 1.39%
27,886
-7,114
-20% -$743K
SNN icon
34
Smith & Nephew
SNN
$12.6B
$2.85M 1.35%
80,000
+30,000
+60% +$1.03M
IQV icon
35
IQVIA
IQV
$40.3B
$2.75M 1.3%
+40,000
New +$2.73M
WCG
36
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.74M 1.3%
35,000
-40,000
-53% -$3.32M
A icon
37
Agilent Technologies
A
$42.3B
$2.72M 1.29%
+65,000
New +$2.51M
REGN icon
38
Regeneron Pharmaceuticals
REGN
$82.6B
$2.71M 1.29%
5,000
-5,000
-50% -$2.71M
SHPG
39
DELISTED
Shire pic
SHPG
$2.67M 1.27%
13,000
+4,000
+44% +$831K
CNC icon
40
Centene
CNC
$32.2B
$2.63M 1.25%
80,000
– –
AMN icon
41
AMN Healthcare
AMN
$1.27B
$2.48M 1.18%
80,000
+5,000
+7% +$148K
PRXL
42
DELISTED
Parexel International Corp
PRXL
$2.38M 1.13%
+35,000
New +$2.28M
WBA
43
DELISTED
Walgreens Boots Alliance
WBA
$2.26M 1.07%
26,488
-13,512
-34% -$1.15M
ACH
44
Accendra Health
ACH
$94.2M
$2.16M 1.03%
60,000
+28,199
+89% +$1.02M
ZTS icon
45
Zoetis
ZTS
$31B
$2.16M 1.02%
45,000
-10,000
-18% -$452K
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$5.07B
$2.14M 1.02%
60,000
+3,686
+7% +$130K
SCAI
47
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$2.09M 0.99%
52,500
-27,500
-34% -$957K
ZBH icon
48
Zimmer Biomet
ZBH
$18.6B
$2.05M 0.97%
20,600
– –
IPXL
49
DELISTED
Impax Laboratories, Inc.
IPXL
$2.02M 0.96%
47,369
-2,631
-5% -$105K
VWR
50
DELISTED
VWR Corporation
VWR
$1.97M 0.93%
69,432
-10,568
-13% -$280K
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q4 2015 Portfolio in Review

As of Q4 2015, Sivik Global Healthcare held 69 positions worth $211M, up 2.1% from $206M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare withdrew a net $6.46M in Q4 2015, closing 9 positions and reducing 24 holdings. Its most notable exit was Gilead Sciences, an estimated $5.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 84% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Cardinal Health worth $7.14M.

  • Sivik Global Healthcare's largest Q4 2015 buy was Cardinal Health: 80,000 shares worth $7.14M.
  • Sivik Global Healthcare added most to HCA Healthcare in Q4 2015, an estimated $3.84M increase.
  • Sivik Global Healthcare's biggest Q4 2015 reduction was HEALTH NET INC, cutting an estimated $6.31M.
  • Sivik Global Healthcare fully exited Gilead Sciences in Q4 2015, selling an estimated $5.4M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $211M portfolio in Q4 2015.
  • Sivik Global Healthcare opened 12 new positions and closed 9 in Q4 2015.
  • Sivik Global Healthcare's portfolio value rose 2.1% quarter-over-quarter to $211M.

Based on Sivik Global Healthcare's 13F filing for Q4 2015, filed 5 Feb 2016.